glp 1 announcement New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Novo Nordisk, Lilly strike deal
Description
Supplied pre-sterilised, Nexa high-performance syringes have been developed to ensure compatibility with drug delivery devices to meet the growing demand for drug products that patients can self-administer from the comfort of their own homes

For nonadherence, the 1year absolute risks of nonadherence stratified according to baseline HbA1c are shown in Figure S1B

Contact Us to explore our safe, transparently sourced, and third-party tested compounded semaglutide options, all prescribed by licensed medical providers
297-OR: A novel GLP-1/FGF21 dual agonist ZT003 has therapeutic potential for obesity, diabetes, and nonalcoholic steatohepatitis

Diabetes 63:36743685
Responsible play tools deserve top billing
